Literature DB >> 24913549

MicroRNAs play a role in spontaneous recovery from acute liver failure.

Katharina John1, Johannes Hadem, Till Krech, Kristin Wahl, Michael P Manns, Steven Dooley, Sandor Batkai, Thomas Thum, Klaus Schulze-Osthoff, Heike Bantel.   

Abstract

UNLABELLED: Acute liver failure (ALF) represents a life-threatening situation characterized by sudden and massive liver cell death in the absence of preexisting liver disease. Although most patients require liver transplantation to prevent mortality, some recover spontaneously and show complete liver regeneration. Because of the rarity of this disease, the molecular mechanisms regulating liver regeneration in ALF patients remain largely unknown. In this study, we investigated the role of microRNAs (miRs) that have been implicated in liver injury and regeneration in sera from ALF patients (n = 63). Patients with spontaneous recovery from ALF showed significantly higher serum levels of miR-122, miR-21, and miR-221, compared to nonrecovered patients. In liver biopsies, miR-21 and miR-221 displayed a reciprocal expression pattern and were found at lower levels in the spontaneous survivors, whereas miR-122 was elevated in both serum and liver tissue of those patients. As compared to nonrecovered patients, liver tissue of spontaneous survivors revealed not only increased hepatocyte proliferation, but also a strong down-regulation of miRNA target genes that impair liver regeneration, including heme oxygenase-1, programmed cell death 4, and the cyclin-dependent kinase inhibitors p21, p27, and p57.
CONCLUSION: Our data suggest that miR-122, miR-21, and miR-221 are involved in liver regeneration and might contribute to spontaneous recovery from ALF. Prospective studies will show whether serological detection of those miRNAs might be of prognostic value to predict ALF outcome.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24913549     DOI: 10.1002/hep.27250

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  29 in total

Review 1.  MicroRNA: a connecting road between apoptosis and cholesterol metabolism.

Authors:  Yogita K Adlakha; Neeru Saini
Journal:  Tumour Biol       Date:  2016-04-22

2.  Letters to the editor.

Authors:  Ronald G Amedee
Journal:  Ochsner J       Date:  2014

Review 3.  [Diagnosis and therapies for acute liver failure: scientific developments].

Authors:  M Ott; T Cantz; A Schneider; M P Manns
Journal:  Internist (Berl)       Date:  2014-11       Impact factor: 0.743

Review 4.  A Tale of Two States: Normal and Transformed, With and Without Rigidity Sensing.

Authors:  Michael Sheetz
Journal:  Annu Rev Cell Dev Biol       Date:  2019-08-14       Impact factor: 13.827

Review 5.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

6.  Mir-24 regulates hepatocyte apoptosis via BIM during acute liver failure.

Authors:  Zhiwen Feng; Zhi Li; Deming Zhu; Wei Ling; Lei Zheng; Liyong Pu; Lianbao Kong
Journal:  Am J Transl Res       Date:  2017-11-15       Impact factor: 4.060

7.  Therapeutic targets for liver regeneration after acute severe injury: a preclinical overview.

Authors:  Hidenobu Kojima; Kojiro Nakamura; Jerzy W Kupiec-Weglinski
Journal:  Expert Opin Ther Targets       Date:  2020-01-10       Impact factor: 6.902

Review 8.  Role of Noncoding RNAs in Acetaminophen-Induced Liver Injury.

Authors:  Vivek Chowdhary; Pipasha Biswas; Kalpana Ghoshal
Journal:  Gene Expr       Date:  2021-03-23

9.  Circulating microRNAs Reveal Time Course of Organ Injury in a Porcine Model of Acetaminophen-Induced Acute Liver Failure.

Authors:  Luisa A Baker; Karla C L Lee; Carolina Palacios Jimenez; Hatim Alibhai; Yu-Mei Chang; Pamela J Leckie; Rajeshwar P Mookerjee; Nathan A Davies; Fausto Andreola; Rajiv Jalan
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

Review 10.  MicroRNAs in the Evaluation and Potential Treatment of Liver Diseases.

Authors:  Amar Mahgoub; Clifford J Steer
Journal:  J Clin Med       Date:  2016-05-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.